Tonix Pharmaceuticals Holding Corp. (TNXP) Press Releases https://ir.tonixpharma.com/news-events/press-releases/rss en-us https://s3.amazonaws.com/equisolve-dev4/tonixpharma/files/theme/images/logo-sm.png Tonix Pharmaceuticals Holding Corp. Logo Equisolve Investor Relations Suite <![CDATA[Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis of Opioid Use in Patients with Fibromyalgia at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1631/tonix-pharmaceuticals-presented-retrospective-u-s Thu, 28 May 26 16:30:00 -0400 https://ir.tonixpharma.com/news-events/press-releases/detail/1631/tonix-pharmaceuticals-presented-retrospective-u-s <![CDATA[Tonix Pharmaceuticals Announces Publication of Phase 1 Clinical Data of TNX-1500, an Fc-Modified anti-CD40L (CD154) Monoclonal Antibody, in the Peer-Reviewed Journal of Clinical Immunology]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1630/tonix-pharmaceuticals-announces-publication-of-phase-1 Wed, 27 May 26 07:00:00 -0400 https://ir.tonixpharma.com/news-events/press-releases/detail/1630/tonix-pharmaceuticals-announces-publication-of-phase-1 <![CDATA[Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at The Professional Society for Health Economics and Outcomes Research (ISPOR) 2026 Annual Meeting]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1629/tonix-pharmaceuticals-presented-retrospective-u-s Tue, 26 May 26 07:00:00 -0400 https://ir.tonixpharma.com/news-events/press-releases/detail/1629/tonix-pharmaceuticals-presented-retrospective-u-s <![CDATA[Tonix Pharmaceuticals to Present Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at ISPOR 2026]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1628/tonix-pharmaceuticals-to-present-retrospective-u-s Thu, 14 May 26 07:00:00 -0400 https://ir.tonixpharma.com/news-events/press-releases/detail/1628/tonix-pharmaceuticals-to-present-retrospective-u-s <![CDATA[Tonix Pharmaceuticals to Participate in Two Investor Conferences in May]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1627/tonix-pharmaceuticals-to-participate-in-two-investor Tue, 12 May 26 16:30:00 -0400 https://ir.tonixpharma.com/news-events/press-releases/detail/1627/tonix-pharmaceuticals-to-participate-in-two-investor <![CDATA[Tonix Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Highlights]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1626/tonix-pharmaceuticals-reports-first-quarter-2026-financial Mon, 11 May 26 16:30:00 -0400 https://ir.tonixpharma.com/news-events/press-releases/detail/1626/tonix-pharmaceuticals-reports-first-quarter-2026-financial <![CDATA[Tonix Pharmaceuticals Secures Commercial Payer Coverage for TONMYA®, Providing Access for ~35 Million U.S. Patients]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1625/tonix-pharmaceuticals-secures-commercial-payer-coverage-for Wed, 06 May 26 07:00:00 -0400 https://ir.tonixpharma.com/news-events/press-releases/detail/1625/tonix-pharmaceuticals-secures-commercial-payer-coverage-for <![CDATA[Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Plans for an Adaptive Phase 2 Field Study of TNX-4800 (anti-Borrelia OspA monoclonal antibody) for the Prevention of Lyme Disease at the 4th Annual Ticks and Tickborne Diseases Symposium at Johns Hopkins University]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1624/tonix-pharmaceuticals-announces-presentation-of-phase-1 Wed, 29 Apr 26 07:00:00 -0400 https://ir.tonixpharma.com/news-events/press-releases/detail/1624/tonix-pharmaceuticals-announces-presentation-of-phase-1 <![CDATA[Tonix Pharmaceuticals Presents Updates on Preclinical Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2026]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1623/tonix-pharmaceuticals-presents-updates-on-preclinical Thu, 23 Apr 26 07:00:00 -0400 https://ir.tonixpharma.com/news-events/press-releases/detail/1623/tonix-pharmaceuticals-presents-updates-on-preclinical <![CDATA[Tonix Pharmaceuticals Announces Publication of Steady-State Pharmacokinetics of TONMYA® After 20 Days of Daily Dosing in the Peer-Reviewed Journal, Clinical Pharmacology in Drug Development]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1622/tonix-pharmaceuticals-announces-publication-of-steady-state Wed, 15 Apr 26 07:00:00 -0400 https://ir.tonixpharma.com/news-events/press-releases/detail/1622/tonix-pharmaceuticals-announces-publication-of-steady-state